Enhancing gene therapy with Circio
Drug Target Review
MAY 22, 2024
Technical vector-specific design optimisation is ongoing, and we plan to build a repertoire of circVec vectors that can be deployed for gene therapy, vaccines, oncology, and cell therapy in the future. We are now running follow-up experiments to track the advantage long-term.
Let's personalize your content